Skip to main content

Reporter Sept 26 2014

Optical imaging in drug therapy screens

Oct. 1, 2014—A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients.

Read more

Seizure mutation impairs receptor

Sep. 30, 2014—Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures.

Read more

Biomarker for diabetic eye disease

Sep. 26, 2014—A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

Read more

A path to sarcoidosis treatment

Sep. 25, 2014—Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

Read more

VUMC well positioned to move forward: Balser

Sep. 25, 2014—He began with a simple thank you. That’s how Jeff Balser, M.D., Ph.D., Vanderbilt’s vice chancellor for Health Affairs and dean of the School of Medicine chose to begin his annual State of the Medical Center address on Tuesday. “I don’t know how to thank you enough,” he said to the Medical Center’s faculty and...

Read more

Elevate town hall series kicks off Sept. 30

Sep. 25, 2014—Beginning Tuesday, Sept. 30, members of Vanderbilt University Medical Center’s leadership team will hold a series of 45-minute town hall presentations that all faculty and staff are encouraged to attend.

Read more

Bradfords’ strong support bolsters melanoma research

Sep. 25, 2014—When something attacks you, you want to attack it back. That’s how Lillian “Tooty” Bradford views her late husband James “Jimmy” Bradford Jr.’s decision to make an initial gift to fund melanoma research at Vanderbilt-Ingram Cancer Center (VICC).

Read more

Annual Flulapalooza event happens Oct. 1

Sep. 25, 2014—Less than 10 seconds — that’s all it takes to roll up your sleeve and be part of next week’s Flulapalooza, Vanderbilt University Medical Center’s mass flu vaccination event that three years ago more than doubled the world record for the total number of vaccinations given in an eight-hour period.

Read more

Cancer progress report calls for added research support

Sep. 25, 2014—There are now approximately 14.5 million cancer survivors in the United States, thanks in large part to advances in cancer research and the development of new anti-cancer therapies.

Read more

Churchwell to depart VHVI; Clair to assume interim role

Sep. 25, 2014—Keith Churchwell, M.D., executive director and chief medical officer for the Vanderbilt Heart and Vascular Institute (VHVI), is departing Vanderbilt and will join Yale-New Haven Health System as vice president and executive director of Cardiovascular Services on Dec. 1.

Read more

Doherty set for next Discovery Lecture

Sep. 25, 2014—Nobel laureate Peter Doherty, Ph.D., who discovered how the immune system recognizes virus-infected cells, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 2.

Read more

Orthopaedic programs honored

Sep. 25, 2014—Vanderbilt Orthopaedics has been named in the Becker’s Hospital Review list of 125 Hospitals and Health Systems With Great Orthopedic Programs.

Read more

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice